Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Sanjay Adhikary, Subrata Roy, Shailesh Budhathoki, Siam Chowdhury, Abbey Stillwell, Alexei G. Basnakian, Alan Tackett, Nathan Avaritt, Mohamed Milad, Mohammad Abrar Alam
TL;DR
This paper corrects a previously published study on new drug compounds that may help treat melanoma by targeting cell structure proteins.
Contribution
The paper provides corrections to a prior study on thiazole-fused derivatives as potential melanoma treatments.
Findings
The paper corrects errors in the original study's data or methodology.
The corrections may impact the interpretation of the compounds' effectiveness against melanoma.
Abstract
Correction for ‘Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors’ by Sanjay Adhikary et al., RSC Med. Chem., 2025, 16, 1105–1130, https://doi.org/10.1039/d4md00719k.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
- —National Institutes of Health10.13039/100000002
- —National Institute of General Medical Sciences10.13039/100000057
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsChemical Synthesis and Analysis · Synthesis of β-Lactam Compounds · Click Chemistry and Applications
The authors regret that the name displayed for compound E17 in the ‘Materials and methods’ section of their article contains an error. The corrected name for compound E17 is (1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-[(3-methyl-2-pyridyl)amino]-8-thia-6-azapentacyclo[11.7.0.0^2,10^.0^5,9^.0^14,18^]icosa-5(9),6,10-trien-17-ol.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.